Literature DB >> 9753276

Sulfur metabolism in ulcerative colitis: investigation of detoxification enzymes in peripheral blood.

M C Pitcher1, E R Beatty, R M Harris, R H Waring, J H Cummings.   

Abstract

Two enzymes of detoxification were studied in blood samples from 27 patients with ulcerative colitis (UC) and 18 controls to determine whether there is an abnormality in sulfur metabolism in UC. Thiol methyltransferase (TMT) activity was measured in erythrocyte membranes as the extent of conversion of 2-mercaptoethanol to S-methyl-2-mercaptoethanol with [3H]methyl-S-adenosyl methionine as methyl donor. Phenol sulfotransferase (PST) activity was measured in platelet homogenates as the extent of sulfation of p-nitrophenol with 3-phosphoadenosine 5-phospho[35S]sulfate (PAPS) as sulfate donor. TMT activity was significantly higher in UC patients (27.0 vs 17.1 nmol/mg protein/hr; P < 0.005). No difference in PST activity was found. We conclude that TMT may be up-regulated in UC to detoxify excess hydrogen sulfide exposed to the peripheral blood compartment. This may arise from either increased luminal sulfide production or reduced colonic detoxification.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9753276     DOI: 10.1023/a:1018867516575

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  40 in total

1.  Antagonistic effects of sulfide and butyrate on proliferation of colonic mucosa: a potential role for these agents in the pathogenesis of ulcerative colitis.

Authors:  S U Christl; H D Eisner; G Dusel; H Kasper; W Scheppach
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

2.  [Protective effect of metronidazole in experimental ulcerative colitis induced by dextran sulfate sodium].

Authors:  T Ohkusa; M Yamada; T Takenaga; C Kitazume; N Yamamoto; M Sasabe; I Takashimizu; Y Tamura; E Sakamoto; H Kurosawa
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1987-10

Review 3.  The genetic origin of responses to drugs.

Authors:  R H Waring; P Emery
Journal:  Br Med Bull       Date:  1995-04       Impact factor: 4.291

4.  Bacteriological studies of experimental ulcerative colitis.

Authors:  A B Onderdonk; J G Bartlett
Journal:  Am J Clin Nutr       Date:  1979-01       Impact factor: 7.045

5.  Non-smoking: a feature of ulcerative colitis.

Authors:  A D Harries; A Baird; J Rhodes
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-06

6.  Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis.

Authors:  M A Chapman; M F Grahn; M A Boyle; M Hutton; J Rogers; N S Williams
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

7.  Thiol methylation pharmacogenetics: heritability of human erythrocyte thiol methyltransferase activity.

Authors:  R A Keith; J Van Loon; L F Wussow; R M Weinshilboum
Journal:  Clin Pharmacol Ther       Date:  1983-10       Impact factor: 6.875

8.  Short chain fatty acids in human large intestine, portal, hepatic and venous blood.

Authors:  J H Cummings; E W Pomare; W J Branch; C P Naylor; G T Macfarlane
Journal:  Gut       Date:  1987-10       Impact factor: 23.059

9.  Utilization of nutrients by isolated epithelial cells of the rat colon.

Authors:  W E Roediger
Journal:  Gastroenterology       Date:  1982-08       Impact factor: 22.682

10.  Ileal and colonic epithelial metabolism in quiescent ulcerative colitis: increased glutamine metabolism in distal colon but no defect in butyrate metabolism.

Authors:  I A Finnie; B A Taylor; J M Rhodes
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

View more
  9 in total

1.  Impaired detoxication of hydrogen sulfide in ulcerative colitis?

Authors:  R Picton; M C Eggo; M J S Langman; S Singh
Journal:  Dig Dis Sci       Date:  2007-01-11       Impact factor: 3.199

2.  Thiol methyltransferase activity in inflammatory bowel disease.

Authors:  W E Roediger; W J Babidge
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

3.  Detoxification of hydrogen sulfide and methanethiol in the cecal mucosa.

Authors:  M D Levitt; J Furne; J Springfield; F Suarez; E DeMaster
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

4.  The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis.

Authors:  M C Pitcher; E R Beatty; J H Cummings
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

5.  Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction.

Authors:  A Fite; G T Macfarlane; J H Cummings; M J Hopkins; S C Kong; E Furrie; S Macfarlane
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

6.  Longitudinal analyses of gut mucosal microbiotas in ulcerative colitis in relation to patient age and disease severity and duration.

Authors:  Alemu Fite; Sandra Macfarlane; Elizabeth Furrie; Bahram Bahrami; John H Cummings; Douglas T Steinke; George T Macfarlane
Journal:  J Clin Microbiol       Date:  2012-12-26       Impact factor: 5.948

Review 7.  Embracing the gut microbiota: the new frontier for inflammatory and infectious diseases.

Authors:  Lieke Wj van den Elsen; Hazel C Poyntz; Laura S Weyrich; Wayne Young; Elizabeth E Forbes-Blom
Journal:  Clin Transl Immunology       Date:  2017-01-20

8.  Reevaluating our understanding of lactulose breath tests by incorporating hydrogen sulfide measurements.

Authors:  Aleksandr Birg; Steve Hu; Henry C Lin
Journal:  JGH Open       Date:  2019-02-22

Review 9.  The role of hydrogen sulfide in aging and age-related pathologies.

Authors:  Bernard W Perridon; Henri G D Leuvenink; Jan-Luuk Hillebrands; Harry van Goor; Eelke M Bos
Journal:  Aging (Albany NY)       Date:  2016-09-27       Impact factor: 5.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.